Royal Bank of Canada
FBLG icon

Royal Bank of Canada’s FibroBiologics FBLG Stock Holding History

Royal Bank of Canada’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
186
+94
+102% +$559 ﹤0.01% 7771
2025
Q4 		$0 Sell
92
-9
-9% -$63 ﹤0.01% 7722
2025
Q3 		$1K Buy
101
+6
+6% +$72 ﹤0.01% 7042
2025
Q2 		$1K Buy
95
+37
+64% +$667 ﹤0.01% 6949
2025
Q1 		$1K Sell
58
-141
-71% -$4.03K ﹤0.01% 6728
2024
Q4 		$8K Sell
199
-67
-25% -$3.6K ﹤0.01% 6421
2024
Q3 		$16K Buy
266
+35
+15% +$2.33K ﹤0.01% 6185
2024
Q2 		$23K Buy
231
+211
+1,055% +$40.2K ﹤0.01% 6021
2024
Q1 		$4K Buy
+20
New +$4.81K ﹤0.01% 6543

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Royal Bank of Canada's FBLG Position: Q1 2026 in Review

Royal Bank of Canada increased its FibroBiologics (FBLG) stake by 102% in Q1 2026, buying an estimated $559 and bringing the position to 186 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7771.

Royal Bank of Canada first reported a position in FBLG in Q1 2024 and has held it in 9 quarters since. The position peaked at $23K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Royal Bank of Canada held 186 shares of FibroBiologics worth $0 as of Q1 2026.
  • Royal Bank of Canada bought 94 FibroBiologics shares in Q1 2026, an estimated $559.
  • FibroBiologics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7771 holding.
  • Royal Bank of Canada first reported a position in FibroBiologics in Q1 2024 and has held it in 9 quarters since.
  • Royal Bank of Canada's FibroBiologics position peaked at $23K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.